Abstract 3389: Genetic and clinical landscape of NUTM1 structural variants
Sara R. Selitsky(University of North Carolina at Chapel Hill), Henry S. Kaplan(Saint Louis University), Adam J. Hockenberry(Tempus Labs (United States)), Michael D. Rollins(Primary Children's Hospital), Alex Rubinsteyn(University of North Carolina at Chapel Hill), Brian Piening(Providence College), Brandon A. Price(Tempus Labs (United States)), Ezra E.W. Cohen(Moores Cancer Center), Kim Ely(Bipar), Jennifer H. Choe(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620